Fundraising Fox

Omniose

St. Louis, US · 23 employees on LinkedIn · 1 known investors

Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae. The company works with pharmaceutical and research partners to advance vaccine candidates through preclinical and clinical development.

Founders & leadership

DH
Dr. HardingPrimary Founder
MF
Mario FeldmanFounder, Scientific Founder
VP
Viliam Pavliak
BM
Benjamin Moutier

Board

DS
Dr. Szymanski
DP
Dr. Projan
DC
Dr. Cooke

Investors · 1

Competitors · 2

by search overlap

Companies competing with Omniose for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Omniose do?
Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae. The company works with pharmaceutical and research partners to advance vaccine candidates through preclinical and clinical development.
Who founded Omniose?
Omniose was founded by Dr. Harding, Mario Feldman.
Who are Omniose's investors?
Omniose's investors include BioGenerator Ventures.
Where is Omniose headquartered?
Omniose is headquartered in St. Louis, US.